Dexcom (DXCM) Work In Process (2010 - 2026)

Dexcom (DXCM) has 13 years of Work In Process data on file, last reported at $136.0 million in Q1 2026.

• On a quarterly basis, Work In Process rose 111.51% year-over-year to $136.0 million in Q1 2026; TTM through Mar 2026 was $136.0 million, a 111.51% increase from a year earlier, with the FY2025 full-year figure at $105.0 million, up 273.67% from the prior year.
• Work In Process for Q1 2026 stood at $136.0 million, up from $105.0 million in the prior quarter.
• Over the last five years, Work In Process for DXCM reached as high as $136.0 million in Q1 2026 and fell as low as $15.8 million in Q1 2022.
• Historically, Work In Process has averaged $51.6 million across 5 years, with a median of $36.4 million in 2023.
• Across the five-year window, Work In Process retreated 12.97% in 2023 and surged 273.67% in 2025, its largest moves.
• Year by year, Work In Process stood at $17.2 million in 2022, then surged by 74.42% to $30.0 million in 2023, then retreated by 6.33% to $28.1 million in 2024, then jumped by 273.67% to $105.0 million in 2025, then rose by 29.52% to $136.0 million in 2026.
• Per Business Quant data, the three most recent Work In Process figures were $136.0 million in Q1 2026, $105.0 million in Q4 2025, and $78.6 million in Q3 2025.